Core Laboratories NV provided earnings guidance for the first quarter and full year of 2013. For the first quarter of 2013, the company expects revenue of approximately $240,000,000 to $250,000,000, after taking into account seasonal effects, and EPS in the $1.12 to $1.18 range.

For the full year, the company expects revenue to range between $1,030,000,000 and $1,070,000,000 with operating margins averaging approximately 31% and incremental margins ranging from 35% to 45%. This operations guidance excludes any foreign currency translations, and a 25% effective tax rate is assumed for the year. This would drive midpoint EPS to a range between $4.96 to $5.22 with a midpoint of $5.09. The midpoint of revenue guidance suggests revenue growth of approximately 7% in a range up to 9% and the EPS guidance suggests earnings growth of approximately 12% in a range up to 16%. The company expects depreciation in 2013 to total approximately $24 million.
The company expects G&A to be around $44 million in 2013. The company expects its effective tax rate in 2013 to be in the 25% range.